EyePoint Inc. share price logo

EyePoint Inc.

NASDAQ: EYPT

Small Cap

$13.58

+0.43

(+3.27%)

as on

EyePoint Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $13.26
    $14.03
    downward going graph

    2.36%

    Downside

    3.31%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.94
    $19.11
    downward going graph

    41.53%

    Downside

    40.72%

    Upside

    downward going graph

EyePoint Inc. share price movements today

Previous Close
$13.15
Open
$13.70
Volume
703.4K
Day's Low - High
$13.26 - $14.03
52 Week Low - High
$7.94 - $19.11

EyePoint Inc. Historical Returns

1 Month Return
+ 14.89 %
3 Month Return
-1.52 %
1 Year Return
+ 52.24 %
3 Year Return
+ 107.65 %
5 Year Return
+ 42.2 %

EyePoint Inc. Stock Fundamentals & Key Indicators

Check EyePoint Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

-3.5118

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-279.4M

Revenue (TTM)

7.6M

Profit Margin

0.00%

Return On Equity TTM

-102.71%

EyePoint Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of EyePoint Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
EyePoint Inc. image
EyePoint Inc.
BUY$1.1B42.2%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.7B57.21%71.2112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$116.5B140.42%27.2235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for EyePoint Inc. Stock including INR - Dollar returns

The EyePoint Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

EyePoint Inc. investment value today

Current value as on today

₹1,65,835

Returns

₹65,835

(+65.83%)

Returns from EyePoint Inc. Stock

₹52,242 (+52.24%)

Dollar Impact

₹13,592 (+13.59%)

Analyst Recommendation on EyePoint Inc. Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for EyePoint Inc.. Average target price of $37

EyePoint Inc. Share Price Target

Get share price movements and forecasts by analysts on EyePoint Inc..

What analysts predicted

63.3%UPSIDE

Target Price

$37

Current Price

$13.58

Analyzed by

16 Analysts

Target

$37.00

EyePoint Inc. target price $37, a slight upside of 63.3% compared to current price of $13.58. According to 16 analysts rating.

Indian Investors' Interest in EyePoint Inc. Stock

Search interest for EyePoint Inc. Stock has increased by 124% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:124% versus previous 30 day period

EyePoint Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
14
11
9
10
11
24
5
0
0
0
Gross Profit
13
10
8
9
10
23
5
0
0
0
Operating Income
-16
-33
-34
-32
-45
-48
-62
-62
-70
-87
EBITDA
-13
-28
-30
-28
-40
-44
-58
-59
-57
-84
Interest Expense
-
-
-
-
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-29
-30
-29
-41
-45
-59
-59
-67
-84
Income Tax Expense
0
0
-
-
0
-
0
-
0
0
Net Income
-14
-29
-30
-29
-41
-45
-59
-59
-67
-84
Net Profit Margin
-100.51%
-250.63%
-325.27%
-278.99%
-357.26%
-184.82%
-1114.31%
-6183.44%
-10904.68%
-12188.51%

EyePoint Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
7
2
20
34
36
41
46
43
31
Gross Profit
1
7
-15
17
28
28
33
41
39
29
Operating Income
-21
-18
-26
-47
-37
-55
-99
-75
-145
-243
EBITDA
-20
-17
-36
-48
-35
-50
-96
-69
-129
-229
Interest Expense
-
0
0
6
7
5
3
1
0
0
Depreciation
0
1
-
2
2
2
2
0
1
2
Income Before Tax
-21
-18
-53
-56
-45
-58
-102
-70
-130
-231
Income Tax Expense
0
0
-25
6
7
5
22
0
0
0
Net Income
-21
-18
-53
-56
-45
-58
-102
-70
-130
-231
Net Profit Margin
-1330.06%
-245.19%
-1795.71%
-278.88%
-131.82%
-158.14%
-246.97%
-153.84%
-302.43%
-739.42%

EyePoint Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-29
-30
-29
-41
-45
-59
-59
-67
-84
Operating Cash Flow
-31
-20
-39
-35
-53
-62
-59
-65
-80
Investing Cash Flow
20
-160
16
-95
39
48
55
-74
59
Financing Cash Flow
0
0
11
151
0
0
7
166
-2
Change in Cash
-10
-180
-10
19
-14
-14
3
27
-24

EyePoint Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-18
-53
-56
-45
-58
-102
-70
-130
-231
Operating Cash Flow
-20
-21
-56
-14
-50
-65
1
-126
-240
Investing Cash Flow
13
-16
0
0
-33
-17
-3
-219
68
Financing Cash Flow
8
60
33
37
216
0
187
164
173
Change in Cash
1
21
-23
22
133
-82
185
-181
2

Global Institutional Holdings in EyePoint Inc.

Funds
Holdings
Federated Hermes Inc
6.76%
HHG PLC
4.3%
The Goldman Sachs Group Inc
1.5%
TCG Crossover Management, LLC
4.28%
Paradigm Biocapital Advisors LP
3.75%
See all

Insights on EyePoint Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, EYPT stock has moved up by 4.2%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 620.0K → 696.0K (in $), with an average increase of 10.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, EYPT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, EYPT has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 7 quarters, -29.36M → -84.83M (in $), with an average decrease of 20.1% per quarter

About EyePoint Inc.

EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for vascular endothelial growth factor mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as EyePoint Pharmaceuticals, Inc. and changed its name to EyePoint, Inc. in December 2025. EyePoint, Inc. was founded in 2000 and is headquartered in Watertown, Massachusetts.
OrganisationEyePoint Inc.
Headquarters480 Pleasant Street, Watertown, MA, United States, 02472
IndustryBiotechnology
CEODr. Jay S. Duker M.D.
E-voting on sharesClick here to vote

Key Management of EyePoint Inc.

Name

Title

Mr. Ron I. Honig Esq.

Chief Legal Officer & Company Secretary

Ms. Jennifer Leonard

Chief People Officer & Senior VP of IT

Mr. David Scott Jones M.A.

Senior Vice President

Mr. Michael J. Maciocio

Chief Manufacturing Officer

Mr. Michael Campbell

Chief Commercial Officer

Dr. Jay S. Duker M.D.

President, CEO & Director

Dr. Ramiro Ribeiro M.D., Ph.D.

Chief Medical Officer

Dr. Marcia Sellos-Moura Ph.D.

Chief Scientific Officer

Ms. Isabelle Lefebvre

Chief Regulatory Officer

Mr. George O. Elston CPA

Executive VP & CFO

FAQs

What is EyePoint Inc. share price today?

EyePoint Inc. share price today is $13.58 as on at the close of the market. EyePoint Inc. share today touched a day high of $14.03 and a low of $13.26.

What is the 52 week high and 52 week low for EyePoint Inc. share?

EyePoint Inc. share touched a 52 week high of $19.11 on and a 52 week low of $7.94 on . EyePoint Inc. stock price today i.e. is closed at $13.58,which is 28.94% down from its 52 week high and 71.03% up from its 52 week low.

What is EyePoint Inc.'s market capitalisation today?

EyePoint Inc. market capitalisation is $0.00T as on .

How to invest in EyePoint Inc. Stock (EYPT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for EyePoint Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in EyePoint Inc. Shares that will get you 0.1105 shares as per EyePoint Inc. share price of $13.58 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy EyePoint Inc. Stock (EYPT) from India?

Indian investors can start investing in EyePoint Inc. (EYPT) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in EyePoint Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on EyePoint Inc. share’s latest price of $13.58 as on June 19, 2026 at 8:45 am IST, you will get 0.7364 shares of EyePoint Inc.. Learn more about fractional shares .

What are the returns that EyePoint Inc. has given to Indian investors in the last 5 years?

EyePoint Inc. stock has given 42.2% share price returns and 27.5% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?